Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hongze Li
Observed name:
H. Li
Institution:
First Hospital of China Medical University
Observed institutions:
Zhejiang Cancer Hospital,
First Hospital of China Medical University,
University of Chinese Academy of Sciences
ORCID:
0009-0008-2682-8371
Observed ORCID:
0009-0008-2682-8371
OpenAlex ID:
A5064759651
A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma
2025
·
Hongze Li
, Jiaqi Zhang
, et al.
·
Journal of Cellular and Molecular Medicine
·
4
Multi-omics analysis of bidirectional liquid–liquid phase separation signatures reveals immunotherapy response and prognosis in renal cell carcinoma
2025
·
Zheyu Wang
, Hongze Li
, et al.
·
BMC Cancer
·
1
PDF
Highly Sensitive Digital Pcr Assay to Detect Kit D816v Mutation in Suspected Mastocytosis Patients
2023
·
K. Wetherby
, S. Hou
, et al.
·
Annals of Allergy Asthma & Immunology
·
1
Case Report: Penile malignant melanoma: insights from a three-case series and literature review on diagnosis and management
2026
·
Xiaoxiao Xu
, Xiaolong Hou
, et al.
·
Frontiers in Oncology
PDF
204P Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small cell lung cancer
2022
·
Y. Fan
, H. Li
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
5
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type